Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis

Translational Research

Volumn 180, Issue , 2017, Pages 37-52.e2

  Buatois, Vanessa ^a   Chatel, Laurence ^a   Cons, Laura ^a   Lory, Sabrina ^a   Richard, Françoise ^a   Guilhot, Florence ^a   Johnson, Zoë ^a   Bracaglia, Claudia ^b   De Benedetti, Fabrizio ^b   de Min, Cristina ^a   Kosco Vilbois, Marie H ^a   Ferlin, Walter G ^a  

^a NOVIMMUNE SA   (Switzerland)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CXCL9 CHEMOKINE; FERRITIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY XMG1.2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; OLIGODEOXYRIBONUCLEOTIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE SYNDROME; DISEASE ACTIVITY; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; HEMOPHAGOCYTIC SYNDROME; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SPLEEN; THROMBOCYTE COUNT; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; PATHOLOGY; SERODIAGNOSIS; SYNDROME;

ANIMALS; BIOMARKERS; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHILD; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERFERON-GAMMA; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MICE, INBRED C57BL; NEUTRALIZATION TESTS; OLIGODEOXYRIBONUCLEOTIDES; SYNDROME;

EID: 84996836504     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.07.023     Document Type: Article

References (40)

1. 1 Tisoncik, J.R., Korth, M.J., Simmons, C.P., et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76 (2012), 16–32.
2. 2 Ferrara, J.L., Abhyankar, S., Gilliland, D.G., Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transplant Proc 25 (1993), 1216–1217.
3. 3 Yokota, S., (Trans.) Influenza-associated encephalopathy–pathophysiology and disease mechanisms Nihon Rinsho 61 (2003), 1953–1958.
4. 4 Wauquier, N., Becquart, P., Padilla, C., Baize, S., Leroy, E.M., Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis, 4, 2010, e837.
5. 5 Clark, I.A., Cowden, W.B., The pathophysiology of falciparum malaria. Pharmacol Ther 99 (2003), 221–260.
6. 6 Imashuku, S., Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44 (2002), 259–272.
7. 7 Sriskandan, S., Altmann, D.M., The immunology of sepsis. J Pathol 214 (2008), 211–223.
8. 8 Falini, B., Pileri, S., De Solas, I., et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75 (1990), 434–444.
9. 9 Finkielman, J.D., Grinberg, A.R., Paz, L.A., et al. Case report: reactive hemophagocytic syndrome associated with disseminated strongyloidiasis. Am J Med Sci 312 (1996), 37–39.
10. 10 Gagnaire, M.H., Galambrun, C., Stephan, J.L., Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children–a series of 12 cases. Pediatrics, 106, 2000, E58.
11. 11 Janka, G.E., Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 63 (2012), 233–246.
12. 12 Ravelli, A., Grom, A.A., Behrens, E.M., Cron, R.Q., Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 13 (2012), 289–298.
13. 13 Harrison, C., Sepsis: calming the cytokine storm. Nat Rev Drug Discov 9 (2010), 360–361.
14. 14 Poltorak, A., He, X., Smirnova, I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998), 2085–2088.
15. 15 Hemmi, H., Takeuchi, O., Kawai, T., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000), 740–745.
16. 16 Behrens, E.M., Canna, S.W., Slade, K., et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 121 (2011), 2264–2277.
17. 17 Canna, S.W., Wrobel, J., Chu, N., et al. Interferon-gamma mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice. Arthritis Rheum 65 (2013), 1764–1775.
18. 18 Lv, S., Han, M., Yi, R., et al. Anti-TNF-alpha therapy for patients with sepsis: a systematic meta-analysis. Int J Clin Pract 68 (2014), 520–528.
19. 19 Pascual, V., Allantaz, F., Arce, E., Punaro, M., Banchereau, J., Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201 (2005), 1479–1486.
20. 20 Shimizu, M., Nakagishi, Y., Yachie, A., Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine 61 (2013), 345–348.
21. 21 Billiau, A., Matthys, P., Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 20 (2009), 97–113.
22. 22 Ethuin, F., Gerard, B., Benna, J.E., et al. Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab Invest 84 (2004), 1363–1371.
23. 23 Schoenborn, J.R., Wilson, C.B., Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96 (2007), 41–101.
24. 24 Huang, K.J., Su, I.J., Theron, M., et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 75 (2005), 185–194.
25. 25 Theron, M., Huang, K.J., Chen, Y.W., Liu, C.C., Lei, H.Y., A probable role for IFN-gamma in the development of a lung immunopathology in SARS. Cytokine 32 (2005), 30–38.
26. 26 Henter, J.I., Elinder, G., Soder, O., et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78 (1991), 2918–2922.
27. 27 Osugi, Y., Hara, J., Tagawa, S., et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89 (1997), 4100–4103.
28. 28 Takada, H., Takahata, Y., Nomura, A., et al. Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis. Clin Exp Immunol 133 (2003), 448–453.
29. 29 Reinhardt, R.L., Liang, H.E., Bao, K., et al. A novel model for IFN-gamma-mediated autoinflammatory syndromes. J Immunol 194 (2015), 2358–2368.
30. 30 Jordan, M.B., Hildeman, D., Kappler, J., Marrack, P., An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104 (2004), 735–743.
31. 31 Pachlopnik, S.J., Ho, C.H., Chretien, F., et al. Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Mol Med 1 (2009), 112–124.
32. 32 Finkelman, F.D., Morris, S.C., Development of an assay to measure in vivo cytokine production in the mouse. Int Immunol 11 (1999), 1811–1818.
33. 33 van Loon, A.P., Ozmen, L., Fountoulakis, M., et al. High-affinity receptor for interferon-gamma (IFN-gamma), a ubiquitous protein occurring in different molecular forms on human cells: blood monocytes and eleven different cell lines have the same IFN-gamma receptor protein. J Leukoc Biol 49 (1991), 462–473.
34. 34 Cilloniz, C., Shinya, K., Peng, X., et al. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog, 5, 2009, e1000604.
35. 35 Lee, S.M., Chan, R.W., Gardy, J.L., et al. Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res, 11, 2010, 147.
36. 36 Shinya, K., Ebina, M., Yamada, S., et al. Avian flu: influenza virus receptors in the human airway. Nature 440 (2006), 435–436.
37. 37 van Dommelen, S.L., Sumaria, N., Schreiber, R.D., et al. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25 (2006), 835–848.
38. 38 Jordan, M.B., Allen, C.E., Weitzman, S., Filipovich, A.H., McClain, K.L., How I treat hemophagocytic lymphohistiocytosis. Blood 118 (2011), 4041–4052.
39. 39 Xu, X.J., Tang, Y.M., Song, H., et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr 160 (2012), 984–990.
40. 40 Matthys, P., Dillen, C., Proost, P., et al. Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels. Eur J Immunol 23 (1993), 2209–2216.